(Q31802549)

English

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

0 references

cystic fibrosis

0 references

Stenotrophomonas maltophilia

1 reference

based on heuristic

inferred from title

author name string

Mooney L

1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Kerr KG

2

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Denton M

3

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

International Journal of Antimicrobial Agents

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

63-66

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Use of aerosolized antibiotics in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for using nebulised antibiotics in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Adhesion of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial-fungal biofilms in flowing water photo-processing tanks

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A new selective differential medium for isolation of Stenotrophomonas maltophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900307-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0924-8579(00)00307-1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31802549&oldid=1542413469"